display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
breast cancer - HER2-positive
la/mBC - HER2 positive - 1st Line (L1)la/mBC - HER2 positive - 2nd Line (L2)
HER2 inhibitor
neratinib based treatment
neratinib ExteNET
neratinib plus capecitabine NALA NALA ...
pertuzumab based treatment
pertuzumab plus trastuzumab PERTAIN
pertuzumab plus trastuzumab plus docetaxel CLEOPATRA PUFFIN
trastuzumab based treatment
trastuzumab plus endocrine therapy SYSUCC-002
tucatinib based treatment
tucatinib plus trastuzumab plus capecitabine HER2CLIMB ... HER2CLIMB

Study type:

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons